Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards

Life Health > Health Insurance > Health Insurance

Coventry shareholders OK Aetna deal

Your article was successfully shared with the contacts you provided.

Aetna (NYSE:AET) has moved another step closer to acquiring Coventry Health Care (NYSE:CVH).

Shareholders voted today at a special meeting to approve a move by Aetna to acquire Coventry.

About 99 percent of the shares that voted supported the deal, and the deal attracted the support of about 78 percent of all outstanding Coventry shares, Coventry said.

Aetna and Coventry still must get approvals from state insurance regulators and wait for the federal antitrust waiting period to expire before they can consummate the deal, Coventry said.

The companies hope to complete the deal by mid-2013.

Aetna has agreed to pay $5.7 billion in cash and stock for Coventry and assume responsibility for $1.6 billion in notes issued by the Bethesda, Md., health insurer.

Aetna now has 18 million enrollees, 437,000 Medicare Advantage enrollees, 1.2 million Medicaid enrollees, and $36 billion in projected 2012 revenue.  

Coventry has 5 million enrollees, 253,000 Medicare Advantage enrollees, 932,000 Medicaid enrollees, and $14 billion in projected 2012 revenue.

Aetna Chairman Mark Bertolini said in a statement that the company welcomes Coventry shareholder approval of the deal.

“We continue to believe that Coventry will complement Aetna’s strategy to expand our core insurance business, increase our presence in the fast-growing government sector and expand our relationships with providers in local geographies,” Bertolini said.

See also:


© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.